Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-19
1993-10-19
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544282, C07D48704, C07D41304, A61K 31505
Patent
active
052545563
ABSTRACT:
The invention relates to C.sub.2-20 alkanoic acid esters of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6, 7,8,9-tetrahydro-9-hydroxy-2 -methyl-4H-pyrido[1,2-a]pyrimidin-4-one, pharmaceutically acceptable acid addition salts thereof, and enantiomeric forms thereof, which are useful in the treatment of warm-blooded animals suffering from psychotic diseases.
REFERENCES:
patent: 4804663 (1989-02-01), Kennis
patent: 5151424 (1992-09-01), Janssens
patent: 5158952 (1992-10-01), Janssen
Janssen Cornelus G. M.
Kennis Ludo E. J.
Knaeps Alfonsus G.
Vandenberk Jan
Berch Mark L.
Janssen Pharmaceutica N.V.
Metz Charles J.
LandOfFree
3-piperidinyl-1,2-benzisoxazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-piperidinyl-1,2-benzisoxazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-piperidinyl-1,2-benzisoxazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1351863